Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03686709 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 27, 2018 (before its estimated June 18, 2019 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres for treatment of hepatocellular carcinoma (HCC) and other metastatic liver disease.
Trial Details
NCT Number NCT03686709
Lead Sponsor University of Tennessee
Collaborators: Biocompatibles UK Ltd
Conditions
(from sponsor)		 Hepatocellular Carcinoma, Radiation Exposure
Related terms Carcinoma, Hepatocellular
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov